Review




Structured Review

Regeneron inc enhanced green fluorescent protein ad. egfp
A , images of mesenteries after treatment with Ad. <t>eGFP</t> , and Ad. eNOS <t>/Ad.</t> <t>Ang1</t> . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Enhanced Green Fluorescent Protein Ad. Egfp, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/enhanced+green+fluorescent+protein+ad++egfp/pmc05330904-54-3-12
Average 90 stars, based on 1 article reviews
enhanced green fluorescent protein ad. egfp - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling"

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling

Journal: The Journal of Physiology

doi: 10.1113/JP273430

A , images of mesenteries after treatment with Ad. eGFP , and Ad. eNOS /Ad. Ang1 . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Figure Legend Snippet: A , images of mesenteries after treatment with Ad. eGFP , and Ad. eNOS /Ad. Ang1 . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.

Techniques Used: Staining

A , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 and antibodies for NG2 and αSMA. B , treatment with Ad. eNOS +Ad. Ang1 significantly increased mural cell coverage. C , Ad. eNOS was unable to stimulate arteriolargenesis by itself but did so when together with Ad. Ang1 . Scale bar: 40 μm. *** P < 0.001 vs . eGFP; ### P < 0.001 vs . eNOS.
Figure Legend Snippet: A , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 and antibodies for NG2 and αSMA. B , treatment with Ad. eNOS +Ad. Ang1 significantly increased mural cell coverage. C , Ad. eNOS was unable to stimulate arteriolargenesis by itself but did so when together with Ad. Ang1 . Scale bar: 40 μm. *** P < 0.001 vs . eGFP; ### P < 0.001 vs . eNOS.

Techniques Used: Staining

A , images of mesenteries after treatment with eNOS with dual VEGF–Ang1 inhibition or eNOS and Ang1 (NO–Tie) with VEGF blockade. B , angiogenesis index. C , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 , Hoechst 33324 and antibodies for Ki67. D – F , quantification of vessel density ( D ), branch point density ( E ) and sprout point density ( F ). G , images of mesenteries after treatment with eNOS with VEGF inhibition, angiopoietin inhibition, dual VEGF–Ang1 or eNOS and Ang1 (NO–Tie) with VEGF blockade stained with isolectin‐B 4 and antibodies for NG2 and αSMA. No arteriolargenesis was seen in any of these conditions. # P < 0.05, ### P < 0.001 vs . eGFP; * P < 0.05, ** P < 0.01 vs . eNOS; + P < 0.05 vs . eNOS–sFlt1–sTie2.
Figure Legend Snippet: A , images of mesenteries after treatment with eNOS with dual VEGF–Ang1 inhibition or eNOS and Ang1 (NO–Tie) with VEGF blockade. B , angiogenesis index. C , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 , Hoechst 33324 and antibodies for Ki67. D – F , quantification of vessel density ( D ), branch point density ( E ) and sprout point density ( F ). G , images of mesenteries after treatment with eNOS with VEGF inhibition, angiopoietin inhibition, dual VEGF–Ang1 or eNOS and Ang1 (NO–Tie) with VEGF blockade stained with isolectin‐B 4 and antibodies for NG2 and αSMA. No arteriolargenesis was seen in any of these conditions. # P < 0.05, ### P < 0.001 vs . eGFP; * P < 0.05, ** P < 0.01 vs . eNOS; + P < 0.05 vs . eNOS–sFlt1–sTie2.

Techniques Used: Inhibition, Staining

Related Articles

Generated:

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling
Article Snippet: Ang1 and Ad. eGFP (enhanced green fluorescent protein) were a gift from Regeneron Inc., Tarrytown, NY, USA (Benest et al . ) and Ad. eNOS (endothelial nitric oxide synthase) from Prof. Keith Channon, University of Oxford (Benest et al . ); Ad. sFlt1 (soluble Fms‐like tyrosine kinase receptor‐1/soluble VEGFR1) was generated by Dr Ewa Paleolog, Imperial College London (Afuwape et al . ) and Ad. sTie2 (soluble Tie2) (Lin et al . ) by Prof. Charles Lin, Vanderbilt University, Nashville, TN, USA.

Staining:

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling
Article Snippet: Ang1 and Ad. eGFP (enhanced green fluorescent protein) were a gift from Regeneron Inc., Tarrytown, NY, USA (Benest et al . ) and Ad. eNOS (endothelial nitric oxide synthase) from Prof. Keith Channon, University of Oxford (Benest et al . ); Ad. sFlt1 (soluble Fms‐like tyrosine kinase receptor‐1/soluble VEGFR1) was generated by Dr Ewa Paleolog, Imperial College London (Afuwape et al . ) and Ad. sTie2 (soluble Tie2) (Lin et al . ) by Prof. Charles Lin, Vanderbilt University, Nashville, TN, USA.

Inhibition:

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling
Article Snippet: Ang1 and Ad. eGFP (enhanced green fluorescent protein) were a gift from Regeneron Inc., Tarrytown, NY, USA (Benest et al . ) and Ad. eNOS (endothelial nitric oxide synthase) from Prof. Keith Channon, University of Oxford (Benest et al . ); Ad. sFlt1 (soluble Fms‐like tyrosine kinase receptor‐1/soluble VEGFR1) was generated by Dr Ewa Paleolog, Imperial College London (Afuwape et al . ) and Ad. sTie2 (soluble Tie2) (Lin et al . ) by Prof. Charles Lin, Vanderbilt University, Nashville, TN, USA.



Similar Products

90
Vector Biolabs ad-cmv-enhanced green fluorescent protein (egfp
Ad Cmv Enhanced Green Fluorescent Protein (Egfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/aav8/pmc11376981-67-0-11
Average 90 stars, based on 1 article reviews
ad-cmv-enhanced green fluorescent protein (egfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Genechem enhanced green fluorescent protein (ad-egfp)
Enhanced Green Fluorescent Protein (Ad Egfp), supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/control+ad+green+fluorescent+protein++gfp+++ad+gfp/pm36990422-68-15-21
Average 90 stars, based on 1 article reviews
enhanced green fluorescent protein (ad-egfp) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Cyagen Biosciences adenovirus (ad)-cytomegalovirus (cmv)-human cdmp1 (hcdmp1)internal ribosome entry site (ires)-enhanced green fluorescent protein (egfp) viral solution
Adenovirus (Ad) Cytomegalovirus (Cmv) Human Cdmp1 (Hcdmp1)internal Ribosome Entry Site (Ires) Enhanced Green Fluorescent Protein (Egfp) Viral Solution, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/adenovirus++ad++cytomegalovirus++cmv++human+cdmp1++hcdmp1+internal+ribosome+entry+site++ires++enhanced+green+fluorescent+protein++egfp++viral+solution/pm27420947-35-13-23
Average 90 stars, based on 1 article reviews
adenovirus (ad)-cytomegalovirus (cmv)-human cdmp1 (hcdmp1)internal ribosome entry site (ires)-enhanced green fluorescent protein (egfp) viral solution - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Regeneron inc enhanced green fluorescent protein ad. egfp
A , images of mesenteries after treatment with Ad. <t>eGFP</t> , and Ad. eNOS <t>/Ad.</t> <t>Ang1</t> . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Enhanced Green Fluorescent Protein Ad. Egfp, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/enhanced+green+fluorescent+protein+ad++egfp/pmc05330904-54-3-12
Average 90 stars, based on 1 article reviews
enhanced green fluorescent protein ad. egfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Thermo Fisher bovine serum albumin rabbit polyclonal anti enhanced green fluorescent protein egfp antibody
A , images of mesenteries after treatment with Ad. <t>eGFP</t> , and Ad. eNOS <t>/Ad.</t> <t>Ang1</t> . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Bovine Serum Albumin Rabbit Polyclonal Anti Enhanced Green Fluorescent Protein Egfp Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/Bovine+Serum+Albumin/pm24164323-90-47-62
Average 99 stars, based on 1 article reviews
bovine serum albumin rabbit polyclonal anti enhanced green fluorescent protein egfp antibody - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Microbix Inc adenovirus–enhanced green fluorescent protein ad-egfp
A , images of mesenteries after treatment with Ad. <t>eGFP</t> , and Ad. eNOS <t>/Ad.</t> <t>Ang1</t> . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Adenovirus–Enhanced Green Fluorescent Protein Ad Egfp, supplied by Microbix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/adenovirus+enhanced+green+fluorescent+protein+ad+egfp/pm22340266-34-10-23
Average 90 stars, based on 1 article reviews
adenovirus–enhanced green fluorescent protein ad-egfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies ad-enhanced green fluorescence protein (egfp)
A , images of mesenteries after treatment with Ad. <t>eGFP</t> , and Ad. eNOS <t>/Ad.</t> <t>Ang1</t> . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Ad Enhanced Green Fluorescence Protein (Egfp), supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/enhanced+green+fluorescent+protein/pm16324108-137-28-47
Average 90 stars, based on 1 article reviews
ad-enhanced green fluorescence protein (egfp) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Somatix Therapy Corp enhanced green fluorescent protein ad-egfp
A , images of mesenteries after treatment with Ad. <t>eGFP</t> , and Ad. eNOS <t>/Ad.</t> <t>Ang1</t> . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.
Enhanced Green Fluorescent Protein Ad Egfp, supplied by Somatix Therapy Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enhanced+green+fluorescent+protein+ad%2E+egfp/enhanced+green+fluorescent+protein+ad+egfp/pm10490763-63-9-26
Average 90 stars, based on 1 article reviews
enhanced green fluorescent protein ad-egfp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


A , images of mesenteries after treatment with Ad. eGFP , and Ad. eNOS /Ad. Ang1 . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.

Journal: The Journal of Physiology

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling

doi: 10.1113/JP273430

Figure Lengend Snippet: A , images of mesenteries after treatment with Ad. eGFP , and Ad. eNOS /Ad. Ang1 . B , angiogenesis index. C , confocal stack images from mesenteric panels stained with isolectin B4 and Hoechst 33324 or Ki67 and Hoechst 33324. D – I , analysis of vessel density ( D ), branch point density ( E ), proliferating endothelial cell density ( F ), exchange vessel density ( G ), conduit vessel density ( H ) and sprout point density ( I ). * P < 0.05, ** P < 0.01, *** P < 0.001 compared with GFP; # P < 0.05 compared with eNOS. Scale bar: 40 μm.

Article Snippet: Ang1 and Ad. eGFP (enhanced green fluorescent protein) were a gift from Regeneron Inc., Tarrytown, NY, USA (Benest et al . ) and Ad. eNOS (endothelial nitric oxide synthase) from Prof. Keith Channon, University of Oxford (Benest et al . ); Ad. sFlt1 (soluble Fms‐like tyrosine kinase receptor‐1/soluble VEGFR1) was generated by Dr Ewa Paleolog, Imperial College London (Afuwape et al . ) and Ad. sTie2 (soluble Tie2) (Lin et al . ) by Prof. Charles Lin, Vanderbilt University, Nashville, TN, USA.

Techniques: Staining

A , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 and antibodies for NG2 and αSMA. B , treatment with Ad. eNOS +Ad. Ang1 significantly increased mural cell coverage. C , Ad. eNOS was unable to stimulate arteriolargenesis by itself but did so when together with Ad. Ang1 . Scale bar: 40 μm. *** P < 0.001 vs . eGFP; ### P < 0.001 vs . eNOS.

Journal: The Journal of Physiology

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling

doi: 10.1113/JP273430

Figure Lengend Snippet: A , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 and antibodies for NG2 and αSMA. B , treatment with Ad. eNOS +Ad. Ang1 significantly increased mural cell coverage. C , Ad. eNOS was unable to stimulate arteriolargenesis by itself but did so when together with Ad. Ang1 . Scale bar: 40 μm. *** P < 0.001 vs . eGFP; ### P < 0.001 vs . eNOS.

Article Snippet: Ang1 and Ad. eGFP (enhanced green fluorescent protein) were a gift from Regeneron Inc., Tarrytown, NY, USA (Benest et al . ) and Ad. eNOS (endothelial nitric oxide synthase) from Prof. Keith Channon, University of Oxford (Benest et al . ); Ad. sFlt1 (soluble Fms‐like tyrosine kinase receptor‐1/soluble VEGFR1) was generated by Dr Ewa Paleolog, Imperial College London (Afuwape et al . ) and Ad. sTie2 (soluble Tie2) (Lin et al . ) by Prof. Charles Lin, Vanderbilt University, Nashville, TN, USA.

Techniques: Staining

A , images of mesenteries after treatment with eNOS with dual VEGF–Ang1 inhibition or eNOS and Ang1 (NO–Tie) with VEGF blockade. B , angiogenesis index. C , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 , Hoechst 33324 and antibodies for Ki67. D – F , quantification of vessel density ( D ), branch point density ( E ) and sprout point density ( F ). G , images of mesenteries after treatment with eNOS with VEGF inhibition, angiopoietin inhibition, dual VEGF–Ang1 or eNOS and Ang1 (NO–Tie) with VEGF blockade stained with isolectin‐B 4 and antibodies for NG2 and αSMA. No arteriolargenesis was seen in any of these conditions. # P < 0.05, ### P < 0.001 vs . eGFP; * P < 0.05, ** P < 0.01 vs . eNOS; + P < 0.05 vs . eNOS–sFlt1–sTie2.

Journal: The Journal of Physiology

Article Title: Differential regulation of blood flow‐induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling

doi: 10.1113/JP273430

Figure Lengend Snippet: A , images of mesenteries after treatment with eNOS with dual VEGF–Ang1 inhibition or eNOS and Ang1 (NO–Tie) with VEGF blockade. B , angiogenesis index. C , sample confocal stack images from rat mesentery 6 days post‐treatment stained with isolectin‐B 4 , Hoechst 33324 and antibodies for Ki67. D – F , quantification of vessel density ( D ), branch point density ( E ) and sprout point density ( F ). G , images of mesenteries after treatment with eNOS with VEGF inhibition, angiopoietin inhibition, dual VEGF–Ang1 or eNOS and Ang1 (NO–Tie) with VEGF blockade stained with isolectin‐B 4 and antibodies for NG2 and αSMA. No arteriolargenesis was seen in any of these conditions. # P < 0.05, ### P < 0.001 vs . eGFP; * P < 0.05, ** P < 0.01 vs . eNOS; + P < 0.05 vs . eNOS–sFlt1–sTie2.

Article Snippet: Ang1 and Ad. eGFP (enhanced green fluorescent protein) were a gift from Regeneron Inc., Tarrytown, NY, USA (Benest et al . ) and Ad. eNOS (endothelial nitric oxide synthase) from Prof. Keith Channon, University of Oxford (Benest et al . ); Ad. sFlt1 (soluble Fms‐like tyrosine kinase receptor‐1/soluble VEGFR1) was generated by Dr Ewa Paleolog, Imperial College London (Afuwape et al . ) and Ad. sTie2 (soluble Tie2) (Lin et al . ) by Prof. Charles Lin, Vanderbilt University, Nashville, TN, USA.

Techniques: Inhibition, Staining